Proathlete Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47K Hold
15
﹤0.01% 168
2026
Q1
$5.28K Hold
15
﹤0.01% 171
2025
Q4
$4.91K Buy
+15
New +$4.76K ﹤0.01% 183
2025
Q3
Sell
-4
Closed -$1.12K 235
2025
Q2
$1.12K Buy
+4
New +$1.13K ﹤0.01% 224

Other funds holding AMGN

Proathlete Wealth Management's AMGN Position: Q2 2026 in Review

Proathlete Wealth Management held its Amgen (AMGN) position steady in Q2 2026 at 15 shares worth $5.47K. The position accounts for ﹤0.01% of the portfolio, ranked #168.

Proathlete Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Proathlete Wealth Management held 15 shares of Amgen worth $5.47K as of Q2 2026.
  • Proathlete Wealth Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Proathlete Wealth Management's portfolio in Q2 2026, its #168 holding.
  • Proathlete Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.